Endocrine Disruptors: Hazards, Risks & Regulations

Webinar Details

When the European Chemicals Agency (ECHA) recently classified endocrine disruption as a serious health and environmental hazard, it pushed this area of evolving regulation and science to the forefront of chemical compliance. Meanwhile, in the U.S., the Environmental Protection Agency's Endocrine Disruptor Screening Program (EDSP) has requested new mammalian endocrine studies for some conventional pesticides. Assessing a chemical's potential to cause endocrine-mediated effects is becoming more urgent as our collective understanding of these chemicals changes — and regulatory paradigms evolve across the globe. How can organizations now approach the hazards, risks, and regulations surrounding endocrine disruptors? 

In this webinar, our experts will delve into the science behind endocrine disruptors, EATS (estrogen, androgen, thyroid, and steroidogenesis) modalities, and the uncertainties around broader effects. We will also explore the new hazard classes introduced in the EU, the challenges of global regulatory harmonization, and potential legal implications for companies operating in multiple jurisdictions. This session is essential for industry and legal professionals who are navigating these complex frameworks. 

Key Takeaways:

• Overview of the endocrine system and how the potential for endocrine-mediated effects are evaluated 
• Differentiate EU and U.S. regulatory approaches and the challenges of navigating complex risk- vs. hazard-based regulatory frameworks  
• Explore the new EU endocrine disruption update to the CLP (classification, labeling, and packaging) guidance amid the evolving regulatory landscape
• Discuss changes in U.S. EPA policies for assessing the potential for endocrine-mediated effects and practical considerations for addressing data call-ins
• Understand the potential legal and regulatory risks and implications of endocrine disruption classifications

Who Should Attend

• The legal community 
• Product developers and brand managers wanting to understand the potential impact of recent changes affecting classification for endocrine disruption
• Data scientists tasked with evaluating test results
• Manufacturers and business leaders concerned about the impacts of endocrine disruptors

CLE Credits

Earn 1 CLE credit for this session.*

*Exponent is accredited as a Multiple Activity Provider in California. Please check with your local jurisdiction for CLE credit approval.